Biotech · Private company · New York, NY, US
Seelos Therapeutics, Inc.
SEC CIK 0001017491
Track this companyFree. Adds Seelos Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- SLS-005Phase 3 · Spinocerebellar Ataxia Type 3ClinicalTrials.gov · fetched Nov 12, 2026
- Intranasal devicePhase 2 · Depressive Disorder, MajorClinicalTrials.gov · fetched Nov 12, 2026
- SLS-002Phase 2 · Depressive Disorder, MajorClinicalTrials.gov · fetched Nov 12, 2026
- TrehaloseAmyotrophic Lateral SclerosisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- STRIDES - a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar AtaxiaPHASE2_PHASE3 · TERMINATED · started Jun 3, 2022ClinicalTrials.gov NCT05490563 · fetched Nov 12, 2026
- HEALEY ALS Platform Trial - Regimen E SLS-005 - TrehalosePHASE2_PHASE3 · COMPLETED · started Feb 21, 2022ClinicalTrials.gov NCT05136885 · fetched Nov 12, 2026
- A Study of SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of SuicidePHASE2 · COMPLETED · started Dec 17, 2020ClinicalTrials.gov NCT04669665 · fetched Nov 12, 2026
- Intermediate-Sized Expanded Access StudyNO_LONGER_AVAILABLEClinicalTrials.gov NCT05597436 · fetched Nov 12, 2026
SEC filings1
- 8-K · CURRENT REPORTSEC EDGAR · filed Nov 22, 2024 · fetched Nov 12, 2026